Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI(®)) for colorectal liver metastases does not predict tumour destruction or long-term outcome.
暂无分享,去创建一个
G. Poston | H. Malik | S. Stättner | D. Dunne | S. Fenwick | E. O’Grady | Robert P. Jones | R. Jones | M. Terlizzo | A. Smethurst